Cheon, Young Koog <br/><br/>
Effects of vardenafil, a phosphodiesterase type-5 inhibitor, on sphincter of Oddi motility in patients with suspected biliary sphincter of Oddi dysfunction.  [electronic resource] 

 -  Gastrointestinal endoscopy  May 2009 
 - 1111-6 p.  digital 
<br/><br/> Publication Type: Clinical Trial; Journal Article 
<br/><br/><label>ISSN: </label>1097-6779 
<br/><br/><label>Standard No.: </label>10.1016/j.gie.2008.07.014  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Administration, Topical<br/>Adult<br/>Aged<br/>Cholangiopancreatography, Endoscopic Retrograde<br/>Common Bile Duct Diseases--drug therapy<br/>Constriction, Pathologic--drug therapy<br/>Female<br/>Humans<br/>Imidazoles--adverse effects<br/>Male<br/>Manometry<br/>Middle Aged<br/>Phosphodiesterase 5 Inhibitors<br/>Phosphodiesterase Inhibitors--adverse effects<br/>Piperazines--adverse effects<br/>Postcholecystectomy Syndrome--drug therapy<br/>Prospective Studies<br/>Sphincter of Oddi--drug effects<br/>Sphincterotomy, Endoscopic<br/>Sulfones--adverse effects<br/>Triazines--adverse effects<br/>Vardenafil Dihydrochloride<br/>Vasodilator Agents--adverse effects